New drug option for teens with ADHD - 2005-07-25
WASHINGTON, July 25 (UPI) -- The Food and Drug Administration has approved a new drug for teens with Attention Deficit Hyperactivity Disorder -- adding to treatment options but also highlighting the debate over psychiatric medication for minors.
The drug, Adderall, was already approved by the FDA for children 12 and under and for people over 18. But approving it for teens greatly increases its reach, because an estimated 2 million U.S. school-age youngsters suffer from ADHD.
Adderall, marketed by Shire Pharmaceuticals Group, was criticized by name in a recent television interview by actor Tom Cruise, who belongs to the Church of Scientology and rejects psychiatric medicine.